| Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia (NCT04001010) | Tetra Bio-Pharma | 2022-07-01 |
| A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy (NCT05276310) | ImmuneOncia Therapeutics Inc. | 2022-06-02 |
| Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers (NCT05204147) | City of Hope Medical Center | 2022-06-02 |
| A Study of DS-9606a in Patients With Advanced Solid Tumors (NCT05394675) | Daiichi Sankyo | 2022-05-31 |
| CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma (NCT05257590) | TaiRx, Inc. | 2022-05-23 |
| HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial (NCT04833023) | Tan Tock Seng Hospital | 2022-05-18 |
| Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma (NCT05364905) | ARCAGY/ GINECO GROUP | 2022-05-09 |
| Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care (NCT05315999) | Gerhild Becker | 2022-05-03 |
| Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer (NCT05315427) | Institut du Cancer de Montpellier - Val d'Aurelle | 2022-05-02 |
| MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors (NCT05076760) | Memgen, Inc. | 2022-04-21 |
| A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors (NCT05298592) | Bristol-Myers Squibb | 2022-03-31 |
| JS001+IMP4297 in Patients With Advanced Cancer (NCT05262842) | Shanghai Junshi Bioscience Co., Ltd. | 2022-03-29 |
| A Study in Patients With Advanced Cancers (NCT05320588) | BiOneCure Therapeutics Inc. | 2022-03-25 |
| ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab (NCT05082259) | Institute of Cancer Research, United Kingdom | 2022-03-02 |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) (NCT05103358) | Aadi Bioscience, Inc. | 2022-02-15 |
| Care Planning Framework in Advanced Cancer (ABC123) (NCT05408507) | University of Colorado, Denver | 2022-02-15 |
| A Study Explore JS001+JS002 in Patients With Advanced Cancer (NCT05128539) | Shanghai Junshi Bioscience Co., Ltd. | 2022-02-10 |
| Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers (NCT05192512) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-01-24 |
| A Feasibility Study of a Virtual Rehabilitation and Physical Activity Program for People With Advanced Cancer (NCT05047042) | University of Alberta | 2022-01-17 |
| Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors (NCT05154630) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-01-14 |
| Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer (NCT05420519) | Chongqing Precision Biotech Co., Ltd | 2021-12-31 |
| The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs (NCT05159245) | Helsinki University Central Hospital | 2021-12-10 |
| Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer (NCT05113199) | Mayo Clinic | 2021-11-18 |
| Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen (NCT04837196) | Astellas Pharma Global Development, Inc. | 2021-11-11 |
| A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors (NCT05136937) | Wuxi People's Hospital | 2021-11-01 |
| An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis (NCT05438342) | Shanghai Pudong Hospital | 2021-11-01 |
| Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer (NCT04146298) | Changhai Hospital | 2021-10-21 |
| Phase II RCT of an Internet-adaptation of Managing Cancer and Living Meaningfully (iCALM) (NCT04757155) | University Health Network, Toronto | 2021-10-13 |
| A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors (NCT05025085) | Agenus Inc. | 2021-10-04 |
| Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. (NCT04823377) | Institut Curie | 2021-09-24 |
| A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors (NCT04991480) | Artios Pharma Ltd | 2021-09-13 |
| Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions (NCT05045040) | Yosuke Uchitomi | 2021-09-06 |
| Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (NCT05060432) | iTeos Belgium SA | 2021-09-06 |
| A Clinical Study of TQB3824 in Subjects With Advanced Cancer (NCT05028218) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-08-31 |
| Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC (NCT04945928) | Ruijin Hospital | 2021-08-27 |
| A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer (NCT05004116) | Memorial Sloan Kettering Cancer Center | 2021-08-09 |
| Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) (NCT04975256) | Mirati Therapeutics Inc. | 2021-07-28 |
| Safety Study of Whole Body Hyperthermia for Advanced Cancer (NCT04467593) | ElmediX | 2021-07-28 |
| Palliative Care Referral System (PCRS) for Cancer Patients With Advanced Disease (NCT04936568) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2021-07-14 |
| Acceptance and Commitment Therapy in Patients With Advanced Lung Cancer (NCT04869267) | Chinese University of Hong Kong | 2021-07-01 |
| The Role of Vitamin D3 Supplementation in Advanced Cancer Patients With Pain (NCT05450419) | Chang Gung Memorial Hospital | 2021-07-01 |
| GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients. (NCT04942756) | Antea Foundation | 2021-06-30 |
| Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors (NCT04900818) | I-Mab Biopharma US Limited | 2021-06-29 |
| A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors (NCT04861987) | Processa Pharmaceuticals | 2021-06-18 |
| AST-021p Study in Advanced Solid Tumors (NCT04864418) | Aston Sci. Inc. | 2021-06-09 |
| Balance, Activity and Quality of Life (NCT04772690) | REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care | 2021-05-01 |
| A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors (NCT04859777) | Monopteros Therapeutics Inc. | 2021-04-13 |
| Complete Versus Partial Preservation of Denonvilliers' Fascia on Urogenital Function in Locally Advanced Rectal Cancer (NCT04672603) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-04-08 |
| Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents (NCT04310345) | Vanderbilt-Ingram Cancer Center | 2021-03-31 |
| Lenvatinib in Locally Advanced Invasive Thyroid Cancer (NCT04321954) | Massachusetts Eye and Ear Infirmary | 2021-03-09 |
| International Study to Evaluate Two Programs of Support for Patients With Advanced Cancer and Their Families (NCT04626349) | Vrije Universiteit Brussel | 2021-02-24 |
| Study of Amblyomin-X in Advanced Solid Tumor (NCT03120130) | União Química Farmacêutica Nacional S/A | 2021-02-15 |
| Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients (NCT04599608) | Imperial College London | 2021-02-01 |
| A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors (NCT04657068) | Artios Pharma Ltd | 2021-01-27 |
| Care Transition Intervention for Patients With Cancer (NCT04640714) | Massachusetts General Hospital | 2021-01-07 |
| Sophie Pilot Implementation and Assessment (NCT03904342) | Boston Medical Center | 2021-01-01 |
| Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors (NCT04678921) | I-Mab Biopharma US Limited | 2020-12-17 |
| FS222 First in Human Study in Patients With Advanced Malignancies (NCT04740424) | invoX Pharma Limited | 2020-12-14 |
| A Prospective Dose Finding Study of Iscador Infusion (NCT04376931) | HaEmek Medical Center, Israel | 2020-12-01 |
| FS120 Phase 1/1b Study in Patients With Advanced Malignancies (NCT04648202) | invoX Pharma Limited | 2020-11-18 |
| Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor (NCT04648254) | Qurient Co., Ltd. | 2020-11-18 |
| Coping Together: Couple-based Interventions for Cancer (NCT04590885) | Duke University | 2020-10-20 |
| Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN) (NCT04606940) | University Health Network, Toronto | 2020-10-19 |
| A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors (NCT04419532) | Daiichi Sankyo | 2020-10-09 |
| Patient-caregiver Communication Intervention for Prognostic Understanding (NCT03833817) | Weill Medical College of Cornell University | 2020-09-20 |
| Adjunctive Effect of Acupuncture for Advanced Cancer Patients With Palliative Care: a Three-arm Randomized Trial (NCT04398875) | The University of Hong Kong | 2020-09-01 |
| A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors (NCT04495296) | Suzhou Transcenta Therapeutics Co., Ltd. | 2020-08-13 |
| Study of GNX102 in Patients With Advanced Solid Tumors (NCT04250597) | GlycoNex, Inc. | 2020-07-29 |
| Resilient Living Program for Patients With Advanced Cancer and Their Caregivers (NCT04480008) | Mayo Clinic | 2020-07-15 |
| Assessing the Immunogenicity of pING-hHER3FL (NCT03832855) | Herbert Lyerly | 2020-07-13 |
| Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway (NCT04407013) | Yonsei University | 2020-06-23 |
| NBE-002 in Patients With Advanced Solid Tumors (NCT04441099) | NBE-Therapeutics AG | 2020-06-19 |
| Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer (NCT04435444) | Memorial Sloan Kettering Cancer Center | 2020-06-15 |
| Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status? (NCT04308356) | Assistance Publique - Hôpitaux de Paris | 2020-06-03 |
| Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (NCT04385654) | West China Hospital | 2020-06-01 |
| A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors (NCT04396821) | Suzhou Transcenta Therapeutics Co., Ltd. | 2020-05-28 |
| LY3214996 +/- HCQ in Pancreatic Cancer (NCT04386057) | Kimberly Perez, MD | 2020-05-27 |
| Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients (NCT04336124) | TaiRx, Inc. | 2020-05-25 |
| AIMS Cancer Outcomes Study (NCT04495790) | Advanced Integrative Medical Science Institute | 2020-05-18 |
| A Trial of ZL-1201 in Subjects With Advanced Cancer (NCT04257617) | Zai Lab (Shanghai) Co., Ltd. | 2020-05-11 |
| Comprehensive Palliative Care for Cancer Patients in Vietnam (NCT05103488) | Vietnam Palliative Health Care Society | 2020-05-07 |
| Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers (NCT04270864) | Gustave Roussy, Cancer Campus, Grand Paris | 2020-04-10 |
| Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) (NCT04330664) | Mirati Therapeutics Inc. | 2020-04-07 |
| COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies (NCT04354246) | Compugen Ltd | 2020-03-31 |
| Effect of Laser Acupuncture on Constipation in Patients With Advanced Cancer (NCT04318808) | Chang Gung Memorial Hospital | 2020-03-01 |
| Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer (NCT04257786) | Assiut University | 2020-03-01 |
| Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study (NCT04095208) | Institut Bergonié | 2020-02-27 |
| First-In-Human Study of EOS884448 in Participants with Advanced Cancers. (NCT04335253) | iTeos Therapeutics | 2020-02-18 |
| A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer (NCT04148937) | Eli Lilly and Company | 2020-01-16 |
| Pembrolizumab in Biliary Tract Cancer (NCT03260712) | European Organisation for Research and Treatment of Cancer - EORTC | 2020-01-07 |
| A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer (NCT04071262) | Eli Lilly and Company | 2019-12-20 |
| A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma (NCT04200963) | Ikena Oncology | 2019-12-18 |
| Videos for Advance Care Planning in Young Adults (NCT04149704) | Dana-Farber Cancer Institute | 2019-12-13 |
| Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies (NCT03546426) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2019-12-12 |
| A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer (NCT04158700) | Eli Lilly and Company | 2019-12-05 |
| Study of the Apatinib Combine With POF Versus POF in Gastric Cancer (NCT04121039) | Fujian Cancer Hospital | 2019-12-01 |
| Clinical Study of Granulocyte Infusion for Advanced Cancer (NCT04124666) | Shanghai East Hospital | 2019-12-01 |
| UC Health Care Planning Study (NCT04012749) | University of California, Los Angeles | 2019-10-25 |
| Exercise Prescription in Patients With Bone Metastases (NCT03979118) | University of Dublin, Trinity College | 2019-10-15 |
| Integration of Palliative Care in an Oncology and Hematology Unit (NCT04089306) | University Hospital, Strasbourg, France | 2019-10-01 |